Sunday, October 19, 2014

10 Best Building Product Stocks To Buy Right Now

Initial public offerings (IPOs) have skyrocketed so far in 2014, particularly for new biotech firms. According to the Financial Times, eight biotech firms raised a total of more than $500 million last week alone.

Here�� a look at two IPOs from last week that were not biotech firms and two of the biotechs��IPOs.

Ladder Capital Corp. (NYSE: LADR) priced its offering of 13.25 million shares on Wednesday night at $17, at the mid-point of its expected range of $16 to $18 a share. Underwriters have a 30-day option on an additional 1.99 million shares. Ladder raised approximately $226 million in the IPO. Shares opened Thursday at around $16.50 but finished the first day of trading at $16.99. They closed Friday at $17.30. Ladder is a commercial real-estate finance firm that uses a proprietary platform to originate conduit loans. It bundles the loans and sells them commercial backed mortgage securities (CMBS).

Continental Building Products Inc. (NYSE: CBPX) priced its IPO on Tuesday night at $14, below the expected range of $16 to $18 a share. Shares opened at $14.52 on Wednesday and hit an intraday high of $17.74 on Thursday. They closed on Friday at $17.30. The company raised $165.2 million on the offering of 11.8 million shares. The company makes and sells gypsum board to the construction industry.

Hot Rising Stocks To Buy Right Now: Telecom Argentina SA (TEO)

Telecom Argentina SA (Telecom) is an Argentina-based company primarily engaged in the provision of national fixed-line telecommunication services, international long-distance service, data transmission and Internet services and mobile telephony. The Company also offers such solutions as online business and Web hosting, virtual private network (VPN), mobile operating systems developed by Microsoft and Blackberry, toll-free telephone numbers, call centers and voice over Internet protocol (VoIP) line, as well as other services mainly aimed at corporate clients. The Company�� subsidiaries are structured in two business segments: Fixed Telephony, comprising Telecom Argentina USA Inc and Micro Sistemas Sociedad Anonima, and Mobile Services, including Telecom Personal SA, Nucleo SA and Springville SA. As of December 31, 2010, the Company�� majority shareholder was Nortel SA, 54.74% of its interest.

Voice, Data and Internet

Telecom Argentina owns a local telephone line network, public long-distance telephone transmission facilities and a data transmission network in the Northern Region. Telecom Argentina also owns a network in the Southern Region. Voice, data and Internet services consists of basic telephone services, international long-distance services, data transmission and internet services, information and communication technology services and other basic telephone services. Telecom Argentina provides basic telephone services, including local and domestic long-distance telephone services and public telephone services. Telecom Argentina provides international telecommunications service in Argentina, including voice and data services and international point-to-point leased circuits.

Telecom Argentina provides data transmission and Internet connectivity services, including traditional dial-up and broadband connections, asymmetric digital subscriber line (ADSL) dedicated lines, private networks, national and international broadcasting signal transport and videoconfe! rencing services. Telecom Argentina provides Information and Communications Technology (ICT) services and value-added solutions. Other services provided by Telecom Argentina include supplementary services, such as call waiting, call forwarding, conference calls, caller identification (ID), voice mail, video calls and itemized billing, and telecommunications consulting and telecommunications equipment and maintenance services.

Telecom Argentina is a provider of Basic telephone services in the Northern Region and provides Basic telephone services in the Southern Region. Telecom Argentina�� fixed-line telephone network includes installed telephones and switchboards, a network of access lines connecting customers to exchanges and trunk lines connecting exchanges and long-distance transmission equipment.

The Company competes with Grupo Telmex Argentina, Telephone2, Impsat, IPlan, Comsat, Telecentro, Telefonica, Netizen, Gigared, UOL, Ertach, Telecentro and Cablevision.

Wireless Telecommunication

Telecom Argentina provides wireless services through its subsidiaries in Argentina and Paraguay. Its subsidiary Telecom Personal S.A. (Telecom Personal) provides wireless telephone service throughout Argentina via cellular and personal communications service (PCS) networks. Telecom Personal�� service offerings include global system for mobile communications (GSM) and 3G wireless communication over universal mobile telecommunications system (UMTS)/high-speed downlink packet access (HSDPA) networks (including general packet radio service (GPRS), enhanced data for GSM evolution (EDGE) and HSDPA high-speed wireless, videoconferencing, full track download, multimedia messaging, online streaming, corporate mailing and BlackBerry solutions) and sale of wireless communication devices (cellular phones, 3G modems, 3G hotspots, wireless Internet and netbooks). The Company also provides cellular and PCS services in Paraguay through Nucleo S.A., a subsidiary of Telecom Pers! onal.

The Company competes with Telecom Personal, Telefonica Moviles, America Movil, Telefonica Celular del Paraguay S.A. and Hola Paraguay S.A.

Advisors' Opinion:
  • [By Garrett Cook]

    In trading on Monday, telecommunications services shares were relative laggards, down on the day by about 0.48 percent. Top losers in the sector included Telecom Argentina SA (NYSE: TEO), down 6.57 percent, and NQ Mobile (NYSE: NQ), off 6.69 percent.

10 Best Building Product Stocks To Buy Right Now: TherapeuticsMD Inc (TXMD)

TherapeuticsMD, Inc., incorporated in 1907, promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network. Through the license agreement, the Company focuses on multispecialty group practices and independent physician associations (IPAs) to sell them subscriptions for software, hardware and content developed for and distributed by Spectrum. Spectrum sells its network to IPAs for equipment and installation. On October 4, 2011, the Company acquired VitaMedMD, LLC (VitaMedMD). As a result of the acquisition, VitaMedMD became a wholly owned subsidiary of the Company.

VitaMedMD is a specialty pharmaceutical company, VitaMed is focused on providing products to the women�� health market. The Company focuses on market both over-the-counter (OTC) and prescription nutritional supplements, drugs, medical foods and other medical products through pharmacies and its Web-site. Its brand includes a range of products for women�� health and associated with pregnancy, child birth, nursing, post birth and menopause. Its OTC product line available through its Website includes prenatal vitamins, DHA, iron supplements, calcium supplements, Vitamin D supplements, women�� multivitamins, natural (non-hormonal) menopause relief, and scar reduction creams. In March 2012, the Company launched its first prescription-only prenatal vitamin, vitaMedMD Plus Rx.

vitaMedMD Plus Prenatal Multi-Vitamin + DHA is a two pill combo pack that contains 18 essential vitamins and minerals and 300 milligrams (mg) of life�� DHA. vitaMedMD is a single dose daily multivitamin that provides 14 vitamins, minerals and 200 mg of vegetarian, plant-pure life�� DHA. vitaMedMD Plus Rx is a product with a single-dose combo-pack containing one prenatal vitamin tablet with Quatrefolic Acid. vitaMedMD Plus Rx is a product with a single-dose daily multivitamin containing Quatrefolic Acid. vitaMedMD Iron-150 is a iron replacement supplement. ! vitaMedMD Menopause Relief with Lifenol Plus Bone Support offers a natural solution for hot flashes, night sweats and mood disturbances. vitaMedMD Calcium + Vitamin D is a dietary supplements that help replenish and maintain beneficial levels of Vitamin D. vitaMedMD Stretch Mark Body Cream contains naturally-derived ingredients, including Peptides, Shea Butter, Sweet Almond Oil and Fruit Extracts, that hydrate, soothe and pamper skin to make it softer, smoother and younger-looking.

Advisors' Opinion:
  • [By Roberto Pedone]

    One under-$10 specialty pharmaceutical player that's starting to trend within range of triggering a big breakout trade is TherapeuticsMD (TXMD), which is focused on the sales, marketing and development of branded and generic pharmaceutical and OTC products primarily for the women's health care market. This stock has been in play with the bulls so far in 2013, with shares up 56%.

    If you take a look at the chart for TherapeuticsMD, you'll notice that this stock has been uptrending strong over the last three months, with shares soaring higher from its low of $2.03 to its recent high of $5.27 a share. During that uptrend, shares of TXMD have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TXMD within range of triggering a big breakout trade.

    Traders should now look for long-biased trades in TXMD if it manages to break out above some near-term overhead resistance levels at $4.93 a share to its 52-week high at $5.27 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 450,661 shares. If that breakout triggers soon, then TXMD will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets off that breakout are $6 to $7 a share.

    Traders can look to buy TXMD off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 4.30 a share, or near its 50-day moving average of $4.15 a share. One can also buy TXMD off strength once it starts to clear those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

  • [By John Udovich]

    Yesterday, mid cap women�� health stock Hologic, Inc (NASDAQ: HOLX) fell more than 10% after disappointing Wall Street on earnings,�meaning it might be time to take a look at it and�small cap women�� health stocks�The Female Health Company (NASDAQ: FHCO) and TherapeuticsMD Inc (NYSEMKT: TXMD) because after all, women account for half the population and these three small caps are all focused on the women�� health:

10 Best Building Product Stocks To Buy Right Now: Valeant Pharmaceuticals International Inc(VRX)

Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the areas of neurology, dermatology, and branded generics. It offers Wellbutrin XL to treat depressive disorders; Xenazine to treat chorea associated with Huntington?s disease; CeraVe to rebuild and repair skin barrier; and Kinerase, a cosmetic product. The company also provides Zovirax ointment to treat initial genital herpes; Xerese to treat recurrent herpes labialis; Elidel to treat atopic dermatitis; and Acanya and Atralin gels to treat acne vulgaris. In addition, it offers Cesamet to treat nausea and vomiting associated with cancer chemotherapy; Tiazac XC to treat hypertension and angina; Wellbutrin to treat depressive illness; Sublinox to treat insomnia; and Lodalis to treat hypercholesterolemia. Further, the company provides Cold-FX to strengthen immune system; Duromine/Metermine for weight loss; Difflam to treat sore throa ts; and Duro-Tuss and Rikodeine to treat dry and chesty cough, as well as various branded generics for treatments, including antibiotics, treatments for cardiovascular and neurological diseases, antifungal medications, and diabetic therapies. Additionally, it offers Bisocard to treat hypertension and angina pectoris; Flucinar, a corticosteroid ointment; and Sachol mouth ulcer gel; Bedoyecta to treat neurotic pain; M.V.I., a hospital dietary supplement for trauma and burns; Tandene to treat fever and headache; Melleril to treat anxiety and depression; and products for therapeutic classes, such as vitamin deficiency, antibacterials, and dermatology. It markets its products in the United States, Canada, Australia, New Zealand, Europe, Latin America, southeast Asia, and South Africa. The company was formerly known as Biovail Corporation and changed its name to Valeant Pharmaceuticals International, Inc. in September 2010. The company was founded in 1960 and is headquartered in M ississauga, Canada.

Advisors' Opinion:
  • [By CanadianValue]

    On the acquisition front, Valeant (VRX) was involved in several transactions including PharmaSwiss, Sanitas, Ortho Dermatologics, Dermik, and iNova. The PharmaSwiss and Sanitas acquisitions should increase Valeant�� European business to well over $600 million in revenues in 2012, which would put Europe at close to 20% of the total business. Ortho Dermatologics and Dermik will help Valeant become one of the leading dermatology companies in the world with over $1 billion in revenues. iNova increased Valeant�� presence in Australia and helped it establish footholds in South Africa and Southeast Asia. Management is optimistic that the new positions in Southeast Asia, South Africa and Russia represent future growth platforms for Valeant.

  • [By Keith Speights]

    "Bidness" is good
    Last week, Obagi Medical Products (NASDAQ: OMPI  ) made our list of humongous performers after Valeant Pharmaceuticals� (NYSE: VRX  ) announced a $344 million bid for the company. This week saw a bidding frenzy, with Obagi shares jumping another 29%.

  • [By Philip Springer]

    This was a big week for the global pharmaceutical industry. First, rumors of one deal suggested a possible return to the industry’s old self-destructive ways. But then two other transactions were announced that signaled continuation of a newer trend that’s much healthier for shareholders.

    On Monday, it was reported that New York-based Pfizer Inc. (NYSE: PFE) had been in talks to acquire AstraZeneca PLC (NYSE: AZN), headquartered in London, for over $100 billion. The companies apparently broke off the discussions.

    If such a transaction were to occur, it would be the latest in a long series of megamergers that characterized the corporate strategies of Pfizer, Swiss drug giant Novartis AG (NYSE: NVS) and others in the 1990s and 2000s. Back then, the aim was to acquire rivals in multibillion-dollar deals that broadened the buyers’ businesses to cover more diseases and new health-care areas.

    The catalyst for this buying binge was the so-called patent cliff, in which some of the sector’s biggest drugs faced the loss of patents that protected them from competition, resulting in reduced revenues and earnings.

    Since then, however, the patent cliff problem has waned because many of those patent expirations have already occurred. And the bigger, combined companies generally have come up short on development of new blockbuster drugs. Also, excessive diversification has brought weak competitive positions in some niches.

    But the current industry trend is for companies to focus more on their core strengths instead of diversifying. Pfizer, Bristol-Myers Squibb (NYSE: BMY), Johnson & Johnson (NYSE: JNJ) and Abbott Laboratories (NYSE: ABT) have made such moves over the last few years in order to focus on what they consider higher-growth prospects.

    Tuesday brought more of the same. Novartis and UK-based GlaxoSmithKline (NYSE: GSK) announced more than $20 billion in deals. Novartis is to sell its animal-drugs busi

10 Best Building Product Stocks To Buy Right Now: Kaman Corporation (KAMN)

Kaman Corporation operates in the aerospace and industrial distribution markets. The company?s Industrial Distribution segment distributes products, including bearings, mechanical and electrical power transmission, fluid power, motion control, and materials handling components. The segment offers its products through approximately 200 branches, distribution centers, and call centers in the United States, including Puerto Rico, as well as in Canada and Mexico. Its Aerospace segment produces and/or markets proprietary aircraft bearings and components; and complex metallic and composite aerostructures for commercial, military, and general aviation fixed and rotary wing aircraft. This segment also provides safing and arming solutions for missile and bomb systems for the U.S. and allied militaries; support for its maritime helicopters and medium-to-heavy lift helicopters; and offers engineering design, analysis, and certification services, as well as subcontracts helicopter wor k. Kaman Corporation also operates in the United Kingdom, Germany, Australia, and New Zealand. The company was founded in 1945 and is headquartered in Bloomfield, Connecticut.

Advisors' Opinion:
  • [By Stephen Simpson, CFA]

    Along those lines, neither ITT, RBC Bearings, nor Kaman (KAMN) are up much on this news - some of that may be due to the fact that the whole space (including Kaydon) was near a 52-week high, but some of it may also be due to the fact that Kaydon was a pretty rare asset in the space and there likely aren't enough strategic buyers to justify pumping up the fair values of those companies on the basis of what a strategic acquirer could (or might) pay.

10 Best Building Product Stocks To Buy Right Now: Xcel Energy Inc.(XEL)

Xcel Energy Inc., through its subsidiaries, engages in the generation, purchase, transmission, distribution, and sale of electricity to residential, commercial, and industrial customers, as well as to public authorities in the United States. The company generates electricity using coal, nuclear, natural gas, hydro, wood, diesel, and wind energy. It also engages in the purchase, transportation, distribution, and sale of natural gas to residential, commercial, and industrial customers. The company serves customers in portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. As of December 31, 2010, it provided electricity services to 3,391,611 customers; and natural gas services to 1,893,250 customers. Xcel Energy, through its joint venture interests in WYCO Development LLC, develops and leases natural gas pipeline, storage, and compression facilities. The company was founded in 1909 and is based in Minneapolis, Minnesota.

Advisors' Opinion:
  • [By Rich Smith]

    Schadenfreude's in season
    Not everyone's opposed to the law, necessarily. For example, Xcel Energy (NYSE: XEL  ) is already working to expand its portfolio of wind-generated power in the state, and two years ago, it put into operation a 19-megawatt solar farm in cooperation with SunPower (NASDAQ: SPWR  ) . As a so-called "investor-owned utility," Xcel is already subject to a target of 30% renewables use by 2020 -- so a law making its rural rivals hit a 20% target probably didn't upset Xcel all that much.

10 Best Building Product Stocks To Buy Right Now: Powershares Etf Fund Trusts Ii (PGX)

The PowerShares Preferred Portfolio (Fund) is based on The BofA Merrill Lynch Core Fixed Rate Preferred Securities Index (Index). The Fund normally invest at least 90% of its total assets in securities that comprise the Index. The Index is designed to replicate the total return of a diversified group of investment-grade preferred securities. The Index is rebalanced on a monthly basis. The Fund seeks investment results that correspond generally to the price and yield (before fees and expenses) of a securities index. The Fund invests in sectors, such as basic materials, financial, utilities and unclassified. Invesco PowerShares Capital Management LLC. is the investment adviser. Advisors' Opinion:
  • [By Lawrence Meyers]

    Public Storage has 10 different series of preferred stock, but I like the Series T because it trades at $21.83, which is more than 12% below par. I don�� see any reason for this discount, and it also boosts the 5.75% dividend (at par) to 6.58% at the current price.

    Preferred Stocks to Buy: PowerShares Preferred Portfolio (PGX)

    Dividend Yield: 6.6%

10 Best Building Product Stocks To Buy Right Now: Fujitsu Ltd (FJTSY)

Fujitsu Limited (Fujitsu), incorporated on June 20, 1935, is engaged in providing solutions in the field of information and communication technology. Along with multifaceted services provision, its business consists of the development, manufacture, sales and maintenance of the high-quality products and electronic devices that make these services possible. The Company operates in three segments: technology solutions, ubiquitous products solutions and device solutions. On June 4, 2009, Fujitsu introduced the docomo PRIME series F-09A mobile handset. On July 15, 2009, Fujitsu announces acquisition of shares in information technology (IT) subsidiary of AUTOBACS SEVEN. In October 2010, the Company and Toshiba Corporation announced that they have completed the merger of their mobile phone businesses. Effective August 15, 2013, Intel Corp acquired Fujitsu Semiconductor Wireless Products Inc, from Fujitsu Semiconductor Ltd, a wholly owned subsidiary of Fujitsu Ltd.

Technology solutions

Fujitsu provides solutions/system integration services focused on information system consulting and integration, and infrastructure services centered on outsourcing services (complete information system operation and management). Fujitsu offers system products, such as servers and storage systems, which form the backbone of information systems, along with network products, such as mobile phone base stations, optical transmission systems and other communications infrastructures. Its services include system integration (system construction), consulting, front-end technologies (automated teller machines (ATMs)), outsourcing services (datacenters, IT operation/management, software as a service (SaaS), application operation/management and business process outsourcing), network services (business networks, distribution of Internet/mobile content), system support services (maintenance and surveillance services for information systems and networks) and security solutions (installation of information systems an! d networks).

Ubiquitous products solutions

Fujitsu offers the personal computers (PCs), mobile phones and other products indispensable for realizing the emerging ubiquitous networked society. In PCs, along with more conventional desktop and notebook models, the Company develops netbooks and products with security features, providing a global lineup that allows customers to choose the product for their application. In mobile phones, it provide a variety of products that include high-performance models featuring specs and water resistance, separable mobile phone handset, and products created from collaborations with brands. Its products include PCs, mobile phones and optical transceiver modules.

Device solutions

LSI devices and electronic components comprise Fujitsu�� Device Solutions. Fujitsu Semiconductor, the Fujitsu operating company in semiconductors, provides LSI devices found in products, such as digital home appliances, automobiles, mobile phones and servers. The Company�� subsidiaries Shinko Electric Industries Co., Ltd. and Fujitsu Component Limited, along with FDK Corporation, provide semiconductor packages and other electronic components, as well as structural components, such as batteries, relays and connectors. Its products include LSI devices, electronic components (semiconductor packages), batteries and structural components (relays and connectors).

Advisors' Opinion:
  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) -- Japanese stocks weakened in early Thursday trading as the yen rose and Wall Street ended mixed, with the Nikkei Stock Average (JP:NIK) falling 1.2% to 15,929.74 after a 1.9% advance a day earlier. With the yen (USDJPY) slightly firmer than in the previous session, some investors sold currency-sensitive exporters, with Fanuc Corp. (JP:6954) (FANUF) down 2%, Kyocera Corp. (JP:6971) (KYOCF) off 1.9%, and Fujitsu Ltd. (JP:6702) (FJTSY) losing 2.3%. News that China would lift a ban on some sales of videogame consoles had sent shares of Nintendo Co. (JP:7974) (NTDOF) shooting 11% higher on Wednesday, but apparent profit-taking sent the stock down 4.2% in early Thursday action. Shares of rival Sony Corp. (JP:6758) (SNE) , however, followed with a 4% rise, also possibly buoyed by a Nikkei Asian Review report that it was planning a "smartphone offensive" in the U.S. and China. Canon Inc. (JP:7751) (CAJ) fell 2% on a separate Nikkei report that the company's 2013 operating profit would miss forecasts. Toshiba Corp. (JP:6502) (TOSYY)

  • [By MARKETWATCH]

    LOS ANGELES (MarketWatch) -- A rising Japanese yen and weak results from Caterpillar Inc. (CAT) overnight sent Tokyo-listed shares lower in early Thursday trade, with the Nikkei Stock Average (JP:NIK) falling 0.4% to 14,363.59, while the Topix also lost 0.4%. With the U.S. dollar remaining below the 98-yen level amid concerns about the health of China's largest banks, some currency-sensitive shares extended their losses after driving the Nikkei Average down 2% in the previous session. Among them, trading house Mitsui & Co. (JP:8031) (MITSY) fell 1.3%, retail major J. Front Retailing Co. (JP:3086) lost 1.2%, auto maker Nissan Motor Co. (JP:7201) (NSANY) retreated 0.6%, and Fujitsu Ltd. (JP:6702) (FJTSY) traded 1% lower. The below-forecast quarterly results and outlook cut from U.S. construction-equipment maker Caterpillar sent its Japanese rivals tumbling, with Komatsu Ltd. (JP:6301) (KMTUF) dropping 3.5% and Hitachi Construction Macheriny Co. (JP:6305) (HTCMF) falling 3.1%. On the upside, Hitachi Ltd. (JP:6501) (HTHIF) soared 5.4% after raising its profit and revenue guidance for the fiscal first hal

No comments:

Post a Comment